Novel role of lactosylceramide in vascular endothelial growth factor-mediated angiogenesis in human endothelial cells

Circulation Research

Volumn 97, Issue 8, 2005, Pages 796-804

  Rajesh, Mohanraj ^a,c   Kolmakova, Antonina ^b   Chatterjee, Subroto ^a,b,c  

^a Johns Hopkins Singapore   (Singapore)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Angiogenesis; Lactosylceramide; Platelet endothelial cell adhesion molecule 1; Vascular endothelial growth factor

Indexed keywords

2 DECANOYLAMINO 3 MORPHOLINO 1 PHENYL 1 PROPANOL; CD31 ANTIGEN; CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE; DIGALACTOSYLCERAMIDE; GLYCOSPHINGOLIPID; LACTOSYLCERAMIDE; LACTOSYLCERAMIDE SYNTHASE; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; SMALL INTERFERING RNA; SU 1498; SYNTHETASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; ENDOTHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; MESOTHELIOMA; METASTASIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULITIS;

ANTIGENS, CD31; CELLS, CULTURED; ENDOTHELIAL CELLS; GALACTOSYLTRANSFERASES; HUMANS; LACTOSYLCERAMIDES; MORPHOLINES; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHOLIPASES A; PROTEIN KINASE C; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 26844440360     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000185327.45463.A8     Document Type: Article

References (41)

1. Folkman JC. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med. 1995;1:27-31.
2. Neufeld G, Cohen T, Gengrinovitch S, Poltrorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13:9-22.
3. Ferrara N. Vascular endothelial growth factor. Eur J Cancer. 1996;32: 2413-2422.
4. Petrova TV, Makinen T, Alitalo K. VEGF expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Exp Cell Res. 1990;253:117-130.
5. Brasen JH, Kiuelä A, Röser K, Rissanen TT, Niemi M, Luft FC, Donath K, Yla-Herttuala S. Angiogenesis, VEGF and platelet-derived growth factor BB expression, iron deposition and oxidation-specific epitopes in stented human coronary arteries. Arterioscler Throm Vas Biol. 2001;21:1720-1726.
6. Zhao Q, Egashira K, Inoue S. Vascular endothelial growth factor is necessary in the development of atherosclerosis by recruiting monocytes in a rat model of long-term inhibition of nitric oxide synthesis. Circulation. 2002;105:1110-1115.
7. Newman PJ. The biology of PECAM-1. J Clin Invest. 1997;99:3-8.
8. Ilan N, Madri JA. PECAM-1: old friend, new partners. Curr Opin Cell Biol. 2003;15:515-524.
9. DeLisser HM, Solomindu CM, Stricter RM. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol. 1997;151:671-677.
10. Cao G, O'Brien CD, Zhou Z, Sanders SM, Greenbaum NJ, DeLisser HM. Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. Am J Cell Physiol. 2002;282:C1181-C1190.
11. Solowiej A, Biswas P, Graesser D, Madri JA. Lack of platelet endothelial cell adhesion molecule-1 attenuates foreign body inflammation because of decreased angiogenesis. Am J Pathol. 2003;162:953-962.
12. Zhou Z, Christofidou-Solomildou M, Garlanda C, DeLisser HM. Antibody against murine PECAM-1 inhibits tumor angiogenesis in mice. Angiogenesis. 1999;3:181-188.
13. O'Brien CD, Cao G, Makriginnakis A, DeLisser HM. Role of immunoreceptor tyrosine-based motifs of PECAM-1 in PECAM-1 dependent cell migration. Am J Physiol Cell Physiol. 2004;287:C1103-C1113.
14. Hakomori SI, Igarashi Y. Gangliosides and glycosphingolipids as modulators of cell growth, adhesion, and transmembrane signaling. Adv Lipid Res. 1993;25:147-162.
15. Chatterjee S. Lactosylceramide stimulates aortic smooth muscle cell proliferation. Biochem Biophys Res Commun. 1991;181:554-561.
16. Chatterjee S, Bhunia AK, Snowden A, Han H. Oxidized low density lippproteins stimulate galactosyltransferase activity, ras activation, p44 mitogen activated protein kinase and c-fos expression in aortic smooth muscle cells. Glycobiology. 1997;7:703-710.
17. Bhunia AK, Han H, Snowden A, Chatterjee S. Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells. J Biol Chem. 1997;271:15642-15649.
18. Chatterjee S. Oxidized LDL and lactosylceramide both stimulate the expression of proliferating cell nuclear antigen and proliferation of aortic smooth muscle cells. Indian J Biochem Biophys. 1997;34:56-61.
19. Bhunia AK, Arai T, Bulkey G, Chatterjee S. Lactosylceramide mediates tumor necrosis factor-α (TNF-α) induced intercellular adhesion molecule-1 (ICAM-1) expression and the adhesion of neutrophil in human umbilical vein endothelial cells. J Biol Chem. 1998;273:34349-34357.
20. Arai T, Bhunia AK, Chatterjee S, Bulkley GB. Lactosylceramide stimulates human neutrophils to upregulate Mac-1, adhere to endothelium, and generate reactive oxygen metabolites in vitro. Circ Res. 1998;82:540-547.
21. Chatterjee S, Shi WY, Wilson, P, Mazumder A. Role of lactosylceramide and MAP kinase in the proliferation of proximal tubular cells in human polycystic kidney disease. J Lipid Res. 1996;37:1334-1344.
22. 2 to stimulate PECAM-1 expression and adhesion of human monocytes to endothelial cells. Proc Natl Acad Sci USA. 2004;101:6490-6495.
23. Chatterjee S, Sekerke CS, Kwiterovich PO. Increased accumulation of glycosphingolipids in familial hypercholesterolemia. J Lipid Res. 1982; 23:513-522.
24. Chatterjee SB, Dey S, Shi WY, Thomas K, Hutchins GM. Accumulation of glycosphingolipids in human atherosclerotic plaque and unaffected aorta tissues. Clycobiology. 1997;7:57-65.
25. Fang Lu, Wei HM, Chowdhury SH, Gong NL, Song J Heng CK, Chatterjee, S. Association of Leu125Val polymorphism of platelet endothelial cell adhesion molecule-1 (PECAM-1) gene and soluble levels of PECAM-1 with coronary artery disease in Asian Indians. Indian J Med Res. 2005;121:92-99.
26. Serebruany VL, Murugesan SR, Pothula A, Semaan H, Gurbel PA. Soluble PECAM-1, but not P-selectin, nor osteonectin identify acute myocardial infarction in patients presenting with chest pain. Cardiology, 1999;91:50-55.
27. Zibara K, Chignier E, Covacho C, Poston R, Canard G, McGregor J. Modulation of expression of endothelial intercellular adhesion molecule-1 (ICAM-1), PECAM-1 and VCAM-1 in aortic arch lesions in apolipoprotein E- deficient compared with wild-type mice. Arterioscler Thromb Vasc Biol. 2000;20:2288-2296.
28. Chatterjee S, Cleveland T, Shi WY, Inokuchi J, Radin NS. Studies of the action of ceramide-like substances (D- and L-PDMP) on sphingolipid glycosyltransferases and purified lactosylceramide synthase. Glycoconj J. 1996;13:481-486.
29. Dvorak HF, Nagy JF, Feng D, Brown LF, Dvorak AM. Vascular permeability factor/VEGF and the significance of microvascular hyperpermiability in angiogenesis. Curr Top Microbiol Immunol. 1999;237:97-132.
30. Strawn LM, McMahon G, App H, Schreck R, Kuchler W, Longhi MP, Hui H, Tang C, Levitzki A, Gazit A, Chen I, Keri G, Orfi. L, Risau W, Flamme I, Ullrich A, Hirth KP, Shawver LK. FLK-1 as a target for tumor inhibition. Cancer Res. 1996;56:3540-3545.
31. Inokuchi J, Radin NS. Preparation of the active isomer of 1-phenyl-2-decanoylamino-3-morpholino-1-propanol, inhibitor of murine glucocerebroside synthase. J Lipid Res. 1987;28:565-571.
32. Chatterjee S, Ghosh N. Oxidized low density lipoprotein stimulates aortic smooth muscle cell proliferation. Glycobiology. 1996;6:303-311.
33. Pannu S, Won JS, Khan M, Singh AK, Singh I. A novel role of lactosylceramide in the regulation of lipopolysaccharide/interferon-γ mediated iNOS synthase gene expression: implications for neuroinflammatory diseases. J Neurosci. 2004;24:5942-5954.
34. Pannu R, Singh AK, Singh I. A novel role of lactosylceramide in the regulation of TNF-α- mediated proliferation of rat primary astrocytes: implications for astrogliosis following neurotrauma. J Biol Chem. 2005; 280:316-324.
35. Mutoh T, Tokuda A, Inokuchi J, Kuriyama M. Glucosylceramide sythase inhibitor inhibits the action of nerve growth factor in PC 12 cells. J Biol Chem. 1998;273:26001-26007.
36. Iwamoto T, Fukumoto S, Kanaoka K, Sakai E, Shibata M, Furukawa K, Kato Y, Mizano A. Lactosylceramide is essential for osteoclastogenesis mediated by macrophage-colony-stimulating factor and receptor activator of nuclear factor κB ligand. J Biol Chem. 2001;276:46031-46038.
37. Gliki G, Wheeler-Jones C, Zachary I. Vascular endothelial growth factor induces protein kinase C (PKC)-dependent Akt/PKB activation and phosphatidylinositol 3′-kinase-mediates PKC delta phosphorylation: role of PKC in angiogenesis. Cell Biol Int. 2002;26:751-759.
38. Xia P, Aiello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek MR, King GL. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest. 1996;98:2018-2026.
39. Jain RK, Schlenger K, Hockel M, Yuan F. Quantitative angiogenesis assays: progress and problems. Nat Med. 1997;3:1203-1208.
40. Auerbach A, Lewis R, Shinners B, Kubai L, Akhtar N. Angiogenesis assays: a critical overview. Clin Chem. 2003;49:32-40.
41. Chae S, Paike JH, Furneaux H, Hla T. Requirement of sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. J Clin Invest. 2004;114:1082-1089.